Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis

Multiple Sclerosis

Volumn 9, Issue 5, 2003, Pages 486-491

  Achiron, Anat ^a,b   Barak, Yoram ^a,b   Rotstein, Zeev ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Disability; EDSS; Multiple sclerosis; Progression

Indexed keywords

BETA INTERFERON; GLATIRAMER; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DATA BASE; DISABILITY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NONPARAMETRIC TEST; ONSET AGE; PARAMETRIC TEST; PREDICTION; PROBABILITY; RELAPSE; REMISSION; SCHOOL CHILD; SCORING SYSTEM; STATISTICAL ANALYSIS; VALIDATION PROCESS;

ADULT; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 0142060272     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458503ms945oa     Document Type: Article

References (20)

1. Goodkin DE, Hertsgaard D, Rudcik RA. Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials. Arch Neurol 1989; 46: 1107-12.
2. Kurtzke JF, Beebe GW, Nagler B, Kurland LT, Auth TL. Studies on the natural history of multiple sclerosis. 8. Early prognostic features of the later course of the illness. J Chronic Dis 1977; 30: 819-30.
3. Weinshenker BG. The natural history of multiple sclerosis: Update 1998. Semin Neurol 1998; 18: 301-307.
4. Liu Y, Albertsson-Wikland K, Karelberg J. Long-term consequences of early linear growth retardation (Stunting) in Swedish children. Pediatric Res 2000; 47: 475-80.
5. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
6. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
7. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R et al. CDC Growth Charts: United States. Advance Data From Vital and Health Statistics; No 314. Hyattsville, Maryland: National Center for Health Statistics, 2000.
8. Sullivan K, Gorstein J, Pradilla A. Growth references. Lancet 1991; 37: 1420-21.
9. Guo SS, Roche AF, Chumlea WC, Johnson C, Kuczmarski RJ, Curtin R et al. Statistical effects of varying sample sizes on the precision of percentile estimates. Am J Hum Biol 2000; 12: 64-74.
10. Cole TJ. Fitting smoothed centile curves to reference data. J R Stat Soc 1988; 151: 385-418.
11. SAS. SAS/STAT User's Guide 6.12: Cary, NC: SAS Institute Inc., 1989.
12. Chatterjee S, Price B. Regression Analysis by Example. New York: John Wiley, 1977.
13. Cottrell DA, Kremenchutzky M, Rice GP, Hader W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: A geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 1999; 122: 625-39.
14. Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin 1995; 13: 119-46.
15. Achiron A, Barak Y. Multiple sclerosis - From probable to definite diagnosis: A 7-year prospective study. Arch Neurol 2000; 57: 974-79.
16. Rozin R, Schiff Y, Kahana E, Soffer D. Vocational status of multiple sclerosis patients in Israel. Arch Phys Med Rehabil 1975; 56: 300-304.
17. Confavreux C, Grimaud J, Vukusic S, Moreau T. Is it possible to predict the evolution of multiple sclerosis? Rev Neurol 1998; 154: 624-28.
18. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000; 19: 453-73.
19. Kristrom B, Wikland KA. Growth prediction models, concept and use. Horm Res 2002; 57(Suppl 2): 66-70.
20. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430-38.